Literature DB >> 7869028

lambda 5, but not mu, is required for B cell maturation in a unique gamma 2b transgenic mouse line.

P E Roth1, B Kurtz, D Lo, U Storb.   

Abstract

gamma 2b transgenic mice have a severe B cell defect, apparently caused by strong feedback inhibition of endogenous H-gene rearrangement coupled with an inability of gamma 2b to provide the survival/maturation functions of mu. A unique gamma 2b transgenic line, named the C line, was found to permit B cell development. When the C line is crossed with a mu-membrane knockout line, gamma 2b+ B cells develop in the homozygous knockout. In contrast, a transgenic line representative of all the other gamma 2b lines is completely B cell deficient when mu-mem is deleted. Strikingly, the C phenotype is dominant in C x other gamma 2b transgenic line crosses. There is no evidence for higher gamma 2b transgene expression or other position effects on the transgene in the C mouse. The sequences of the three gamma 2b transgene copies in the C line are identical to that of the original transgene. These results have led to the conclusion that in the C line the transgene integration constitutively induces a gene whose expression can replace mu. To more clearly delineate the stage at which the altered phenotype of the C line is expressed, C mice were crossed onto a lambda 5 knockout background. In the absence of lambda 5, the C line produces no B cells. Since it was also found that gamma 2b can associate with the surrogate light chain (sL; lambda 5/Vpre-B), the crosses between C line gamma 2b mice and lambda 5 knockout mice suggest that gamma 2b/sL is required for B cell maturation in this mouse line. Thus, gamma 2b alone is unable to replace mu for pre-B cell survival/maturation; however, in combination with an unknown factor and the sL, gamma 2b can provide these nurturing functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869028      PMCID: PMC2191911          DOI: 10.1084/jem.181.3.1059

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

Review 1.  Proliferation kinetics and the lifespan of B cells in central and peripheral lymphoid organs.

Authors:  D G Osmond
Journal:  Curr Opin Immunol       Date:  1991-04       Impact factor: 7.486

2.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

Authors:  G Nuñez; L London; D Hockenbery; M Alexander; J P McKearn; S J Korsmeyer
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

Review 3.  Neoplastic development in B-lymphocytes.

Authors:  M Potter
Journal:  Carcinogenesis       Date:  1990-01       Impact factor: 4.944

4.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

5.  Flow cytometric analysis of cell proliferation dynamics in the B cell compartment of the mouse.

Authors:  I Förster; P Vieira; K Rajewsky
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

6.  B cell abnormalities induced by a mu Ig transgene extend to L chain isotype usage.

Authors:  S Rath; A Nisonoff; E Selsing; J M Durdik
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

7.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Mutation pattern of immunoglobulin transgenes is compatible with a model of somatic hypermutation in which targeting of the mutator is linked to the direction of DNA replication.

Authors:  B Rogerson; J Hackett; A Peters; D Haasch; U Storb
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Feedback inhibition of immunoglobulin gene rearrangement by membrane mu, but not by secreted mu heavy chains.

Authors:  J Manz; K Denis; O Witte; R Brinster; U Storb
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

10.  Inhibition of immunoglobulin gene rearrangement by the expression of a lambda 2 transgene.

Authors:  J Hagman; D Lo; L T Doglio; J Hackett; C M Rudin; D Haasch; R Brinster; U Storb
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Gamma 2b transgenic mice as a model for the role of immunoglobulins in B cell development.

Authors:  U Storb; P Roth; B K Kurtz
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

2.  Independent Roles of Switching and Hypermutation in the Development and Persistence of B Lymphocyte Memory.

Authors:  Alexander D Gitlin; Lotta von Boehmer; Anna Gazumyan; Ziv Shulman; Thiago Y Oliveira; Michel C Nussenzweig
Journal:  Immunity       Date:  2016-03-02       Impact factor: 31.745

3.  Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors.

Authors:  S L Pogue; C C Goodnow
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

4.  IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta.

Authors:  Ari Waisman; Manfred Kraus; Jane Seagal; Snigdha Ghosh; Doron Melamed; Jian Song; Yoshiteru Sasaki; Sabine Classen; Claudia Lutz; Frank Brombacher; Lars Nitschke; Klaus Rajewsky
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.